FIELD: chemistry.
SUBSTANCE: invention relates to novel substituted 4-aryl-1,4-dihydro-1,6-naphthyridine-3-carboxamides, method for production thereof, use thereof to produce a medicinal agent which inhibits MR activity.
EFFECT: improved method.
11 cl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
REPLACED DIHYDROPYRAZOLONES AS INHIBITORS OF HIF-PROLYL-4-HYDROXYLASE | 2009 |
|
RU2509080C9 |
NEW DERIVATIVES OF HYDANTOIN AS INHIBITORS OF METAL PROTEINASES | 2005 |
|
RU2376301C2 |
DERIVATIVES OF PROPIONIC ACIDS AND THEIR USING AS hPPARs ACTIVATORS | 2003 |
|
RU2316539C2 |
NOVEL HYDANTOIN DERIVATIVES AS METALLOPROTEINASE INHIBITORS | 2005 |
|
RU2378269C2 |
PIPERIDINYLPYRAZOLOPYRIMIDINONES AND USE THEREOF | 2015 |
|
RU2713937C2 |
NEW AZAQUINOLINE DERIVATIVES | 2018 |
|
RU2773290C2 |
BICYCLIC CONDENSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS | 2016 |
|
RU2684324C1 |
CYCLIC AMINE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS | 2011 |
|
RU2565596C2 |
COMPOUNDS INHIBITING METALLOENZYMES | 2017 |
|
RU2764666C2 |
SUBSTITUTED DIHYDROPYRAZOLONES FOR TREATING CARDIOVASCULAR AND HEMATOLOGIC DISEASES, USE THEREOF, DRUG AND METHOD OF TREATING AND/OR PREVENTING | 2012 |
|
RU2611012C2 |
Authors
Dates
2012-12-27—Published
2008-02-19—Filed